Literature DB >> 19181420

Massive, fatal, intracardiac thrombosis associated with prothrombin complex concentrate.

Otis Warren1, Barry Simon.   

Abstract

Prothrombin complex concentrates are frequently used to rapidly reverse anticoagulation with vitamin K antagonists associated with life-threatening bleeding. We report a patient receiving warfarin who presented to the emergency department with an international normalization ratio greater than 12.8 in cardiac tamponade and received prothrombin complex concentrate for rapid reversal of anticoagulation. On correction of the tamponade, the patient developed a massive and fatal right-sided ventricular thrombus. Thrombogenic complications of treatment with prothrombin complex concentrate have been reported before. Caution should be used when using prothrombin complex concentrates for reversal of anticoagulation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19181420     DOI: 10.1016/j.annemergmed.2008.12.027

Source DB:  PubMed          Journal:  Ann Emerg Med        ISSN: 0196-0644            Impact factor:   5.721


  8 in total

1.  Prothrombin complex concentrates utility for warfarin-associated hemorrhage.

Authors:  Secgin Soyuncu; Savas Aslan; Halil Mutlu; Firat Bektas
Journal:  Int J Clin Exp Med       Date:  2015-02-15

2.  Low-dose Prothrombin Complex Concentrate for Warfarin-Associated Intracranial Hemorrhage with INR Less Than 2.0.

Authors:  Wesley R Zemrak; Kathryn E Smith; Stephen S Rolfe; Teresa May; Robert L Trowbridge; Timothy L Hayes; Gene A Grindlinger; David B Seder
Journal:  Neurocrit Care       Date:  2017-12       Impact factor: 3.210

Review 3.  Clinical review: Prothrombin complex concentrates--evaluation of safety and thrombogenicity.

Authors:  Benny Sørensen; Donat R Spahn; Petra Innerhofer; Michael Spannagl; Rolf Rossaint
Journal:  Crit Care       Date:  2011-01-12       Impact factor: 9.097

4.  Activated prothrombin complex concentrates for the reversal of anticoagulant-associated coagulopathy.

Authors:  Nadia I Awad; Craig Cocchio
Journal:  P T       Date:  2013-11

5.  Use of Confidex to control perioperative bleeding in pediatric heart surgery: prospective cohort study.

Authors:  Chiara Giorni; Zaccaria Ricci; Francesca Iodice; Cristiana Garisto; Isabella Favia; Angelo Polito; Adriano Carotti; Paola Cogo
Journal:  Pediatr Cardiol       Date:  2013-07-11       Impact factor: 1.655

Review 6.  Early and individualized goal-directed therapy for trauma-induced coagulopathy.

Authors:  Herbert Schöchl; Marc Maegele; Cristina Solomon; Klaus Görlinger; Wolfgang Voelckel
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2012-02-24       Impact factor: 2.953

7.  Prothrombin complex concentrate in the reduction of blood loss during orthotopic liver transplantation: PROTON-trial.

Authors:  Freeha Arshad; Brigitte Ickx; Rachel T van Beem; Wojciech Polak; Frank Grüne; Frederik Nevens; Minna Ilmakunnas; Anna-Maria Koivusalo; Helena Isoniemi; Paul F W Strengers; Henk Groen; Herman G D Hendriks; Ton Lisman; Jacques Pirenne; Robert J Porte
Journal:  BMC Surg       Date:  2013-07-01       Impact factor: 2.102

8.  Comparison of 3-Factor Prothrombin Complex Concentrate and Low-Dose Recombinant Factor VIIa for Warfarin Reversal.

Authors:  Scott A Chapman; Eric D Irwin; Nada M Abou-Karam; Nichole M Rupnow; Katherine E Hutson; Jeffrey Vespa; Robert M Roach
Journal:  World J Emerg Surg       Date:  2014-04-15       Impact factor: 5.469

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.